JPS6456618A - Sustained release steroidal rectal administration pharmaceutical - Google Patents
Sustained release steroidal rectal administration pharmaceuticalInfo
- Publication number
- JPS6456618A JPS6456618A JP21428087A JP21428087A JPS6456618A JP S6456618 A JPS6456618 A JP S6456618A JP 21428087 A JP21428087 A JP 21428087A JP 21428087 A JP21428087 A JP 21428087A JP S6456618 A JPS6456618 A JP S6456618A
- Authority
- JP
- Japan
- Prior art keywords
- fatty
- rectal administration
- oily base
- blending
- prednisolone acetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PURPOSE:To obtain the titled readily producible pharmaceutical, having a delayed elution rate of an active ingredient and long duration of sustained blood level without any side effects, by blending a fatty and oily base with prednisolone acetate which is a synthetic adrenocortical hormone having anti- inflammatory action. CONSTITUTION:A sustained release steroidal rectal administration pharmaceutical obtained by blending a fatty and oily base selected from the group consisting of animal and vegetable fats and oils, mineral oils and glycerol esters of fatty acids with prednisolone acetate. The amount thereof blended is preferably within the range of 0.1-20wt.%, especially 0.2-10wt.% in the rectal administration pharmaceutical, which is prepared by blending and dispersing the prednisolone acetate with the fatty and oily base according to a conventional method and forming a solid suppository having 30-37 deg.C melting point or filling the blend or dispersion in an injection type rectal administration tube. Furthermore, the aforementioned fatty and oily base is preferably a solid at ordinary temperature and has 26-37 deg.C, especially 30-37 deg.C melting point.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21428087A JPS6456618A (en) | 1987-08-28 | 1987-08-28 | Sustained release steroidal rectal administration pharmaceutical |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21428087A JPS6456618A (en) | 1987-08-28 | 1987-08-28 | Sustained release steroidal rectal administration pharmaceutical |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6456618A true JPS6456618A (en) | 1989-03-03 |
Family
ID=16653117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP21428087A Pending JPS6456618A (en) | 1987-08-28 | 1987-08-28 | Sustained release steroidal rectal administration pharmaceutical |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6456618A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0511310A1 (en) * | 1990-01-17 | 1992-11-04 | STULTS, Jerry F | Non-aqueous emulsion of silicone oil and stearine |
JPH04346916A (en) * | 1991-05-24 | 1992-12-02 | Iwaki Seiyaku Kk | Base for suppository |
-
1987
- 1987-08-28 JP JP21428087A patent/JPS6456618A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0511310A1 (en) * | 1990-01-17 | 1992-11-04 | STULTS, Jerry F | Non-aqueous emulsion of silicone oil and stearine |
JPH04346916A (en) * | 1991-05-24 | 1992-12-02 | Iwaki Seiyaku Kk | Base for suppository |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69013923T2 (en) | MEDICINAL FORMULATIONS. | |
US5532002A (en) | Gelatin pharmaceutical formulations | |
CA1264670A (en) | Treatment of skin disorders | |
AU2002214953A1 (en) | Pharmaceutical composition for the systematic administration of pharmacologically active ingredients containing polyol fatty acid esters | |
IE42692L (en) | Oestrogenic compositions | |
EP0177368A3 (en) | A novel drug delivery system and method of preparation thereof | |
CA2408915A1 (en) | Self-emulsifying active substance formulation and use of this formulation | |
KR950007873A (en) | Biologics Sustained-Release Pharmaceutical Formulations | |
AU562270B2 (en) | Edible fat compositions and process | |
KR920703024A (en) | Osmotic Oral Formulations for Modification of Fertility | |
CA2245733A1 (en) | Edible vegetable fat-composition | |
IE42496L (en) | Fat product | |
US20070148312A1 (en) | Non-hydrogenated vegetable oil based shortening containing an elevated diglyceride emulsifier composition | |
JPS6456618A (en) | Sustained release steroidal rectal administration pharmaceutical | |
JPS5716818A (en) | Steroid fatty emulsion | |
US4181721A (en) | Depot preparations in an oily, unsaturated solution for intramuscular injection | |
IE790821L (en) | Steroid-containing composition | |
GB1231412A (en) | ||
EP0100156A3 (en) | A method for combatting blackgrass in cereal crops and compositions therefor | |
JPH06253738A (en) | Release oil composition | |
JPS6121049A (en) | Production of whipping shortening | |
CA2293367A1 (en) | Wax esters enriched in .omega.-3 unsaturated fatty acids, their preparation and their use | |
ES8401721A1 (en) | Non-irritating injectable dosage forms | |
US1034161A (en) | Cholesterin preparation. | |
JPS5633028A (en) | Compounded emulsifier using for fats and oils for roll in |